At the time of writing, Mesa Laboratories, Inc [MLAB] stock is trading at $103.4, up 2.75%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MLAB shares have gain 7.31% over the last week, with a monthly amount glided 3.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Mesa Laboratories, Inc [NASDAQ: MLAB] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Underweight rating and assigned the stock a price target of $120. Previously, Evercore ISI upgraded its rating to Outperform on January 04, 2024, and elevated its price target to $125. On January 04, 2021, downgrade downgraded it’s rating to In-line but maintained its price target of $300 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Sector Weight rating and suggested a price target of $287 on November 10, 2020. JP Morgan initiated its recommendation with a Neutral and recommended $260 as its price target on October 02, 2020. In a note dated August 26, 2019, Evercore ISI initiated an Outperform rating and provided a target price of $250 on this stock.
For the past year, the stock price of Mesa Laboratories, Inc fluctuated between $86.04 and $155.12. Currently, Wall Street analysts expect the stock to reach $120 within the next 12 months. Mesa Laboratories, Inc [NASDAQ: MLAB] shares were valued at $103.4 at the most recent close of the market. An investor can expect a potential return of 16.05% based on the average MLAB price forecast.
Analyzing the MLAB fundamentals
According to Mesa Laboratories, Inc [NASDAQ:MLAB], the company’s sales were 240.98M for trailing twelve months, which represents an 5.49% jump. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 100.72 points at the first support level, and at 98.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 104.91, and for the 2nd resistance point, it is at 106.41.
Ratios To Look Out For
It is important to note that Mesa Laboratories, Inc [NASDAQ:MLAB] has a current ratio of 0.63. As well, the Quick Ratio is 0.47, while the Cash Ratio is 0.17. Considering the valuation of this stock, the price to sales ratio is 2.34, the price to book ratio is 3.53.
Transactions by insiders
Recent insider trading involved Owens Gary M, President and CEO, that happened on Jun 16 ’25 when 1939.0 shares were sold. SVP Operations, Archbold Brian David completed a deal on Jun 16 ’25 to sell 472.0 shares. Meanwhile, CFO Sakys John sold 642.0 shares on Jun 16 ’25.
